Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ensysce Biosciences Inc (NQ: ENSC )

0.7027 +0.0327 (+4.88%)
Streaming Delayed Price Updated: 1:39 PM EST, Nov 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ensysce Biosciences Inc

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Ensysce Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results
Via ACCESSWIRE
Ensysce Biosciences Announces Completion of Enrollment for Groundbreaking Opioid Overdose Protection Study
Via ACCESSWIRE
Ensysce Biosciences And 2 Other Stocks Under $2 Insiders Are Aggressively Buying
The Dow Jones rose around 40 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny... 
Via Benzinga
Dr. Lynn Kirkpatrick, Featured Speaker to Discuss Ensysce Overdose Protection Platform at DCAT Seminar
Via ACCESSWIRE
ObsEva, Ensysce Biosciences And 2 Other Stocks Under $1 Insiders Are Aggressively Buying
The Dow Jones jumped by more than 300 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
Ensysce Biosciences Announces Critical Step in Human Abuse Potential Study of PF614 With Database Lock
Via ACCESSWIRE
Ensysce Biosciences Provides Corporate Update
Via ACCESSWIRE
Ensysce Biosciences Announces Initiation of Final Stage of Groundbreaking Opioid Overdose Protection Phase 1 Study
Via ACCESSWIRE
Ensysce Biosciences Announces Successful Completion of Clinical Portion of Oral Human Abuse Potential Trial
Via ACCESSWIRE
Stocks That Hit 52-Week Lows On Tuesday
  During Tuesday, 79 stocks hit new 52-week lows. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Ensysce Biosciences Receives Positive Nasdaq Listing Determination
Via ACCESSWIRE
Ensysce Biosciences to Present its Overdose Protection Program at the 4th Annual NIH 'HELPING END ADDICTION LONG-TERM' (HEAL) Meeting
Via ACCESSWIRE
Ensysce Biosciences, Inc. Announces Closing of $3.0 Million Registered Direct Offering Priced at-the-Market Under NASDAQ Rules
Via ACCESSWIRE
Ensysce Biosciences, Inc. Announces $3 Million Registered Direct Offering
Via ACCESSWIRE
Over $12 Million Bet On TD Holdings? Check Out These 3 Penny Stocks Insiders Are Buying
The Federal Reserve on Wednesday raised its benchmark rate by 0.25%, marking the central bank's second consecutive policy downshift. When insiders purchase or sell shares, it indicates their confidence... 
Via Benzinga
Ensysce Biosciences Announces the Distribution of Series A Preferred Stock to Holders of Its Common Stock
Via ACCESSWIRE
Why Ensysce Biosciences Stock Is Exploding Higher During Wednesday's Session
Ensysce Biosciences Inc (NASDAQ: ENSC) shares are trading higher by 21.81% to $0.82 Wednesday after the company announced initiation of the final stage of its opioid overdose protection Phase 1 study.... 
Via Benzinga
Nasdaq Falls 50 Points; eHealth Shares Spike Higher
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping around 50 points on Wednesday. The Dow traded down 0.12% to 33,694.64 while the NASDAQ fell 0.44% to 11,284.18.... 
Via Benzinga
Nasdaq Down Over 200 Points; AT&T Posts Upbeat Earnings
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping more than 200 points on Wednesday. The Dow traded down 1.10% to 33,364.09 while the NASDAQ fell 1.92% to 11,116.96.... 
Via Benzinga
Why Grom Social Enterprises Shares Are Trading Lower By 30%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) shares surged 85% to $2.2200. Sonoma Pharmaceuticals and EMC Pharma announced Department of Defense DAPA registration for Microcyn(R) Rx products. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Ensysce Biosciences to Present at Diamond Equity Research 2023 Virtual Emerging Growth Invitational
Via ACCESSWIRE
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Ensysce Biosciences Issues 2023 Shareholder Letter
Via ACCESSWIRE
Analyzing Ensysce Biosciences's Short Interest
Ensysce Biosciences's (NASDAQ:ENSC) short percent of float has fallen 83.99% since its last report. The company recently reported that it has 143 thousand shares sold short, which is 2.6% of all... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS